Antipsychotics. BMF 84 - Antipsychotics

Size: px
Start display at page:

Download "Antipsychotics. BMF 84 - Antipsychotics"

Transcription

1 Antipsychotics BMF 84 - Antipsychotics Antipsychotic medications (neuroleptics) are used for the treatment of psychosis, mainly schizophrenia and manic depression (bipolar disorder). They reduce symptoms such as hallucinations, delusions, and paranoia, and can also be used to help severe anxiety or depression. Antipsychotic medications have been available for the treatment of psychosis for over half a century. The first being chlorpromazine (Thorazine), introduced in the early 1950 s. The list now extends to over 20 different compounds. Antipsychotics act by blocking dopamine receptors in the brain and interfering with dopaminergic transmission. Side effects include movement disorders similar to Parkinson s disease, such as shaking/tremor, involuntary body movements and inner restlessness. These are referred to as extrapyramidal symptoms, and can be controlled with anticholinergic drugs such as orphenadrine and procyclidine. Other side effects include lethargy, weight gain and sexual dysfunction. Longer term there is increased risk of developing type 2 diabetes, high blood pressure, heart problems and osteoporosis. Antipsychotics are may be classified as typical or atypical, or first and second generation respectively. Typical antipsychotics include; Chlorpromazine, Haloperidol, Pimozide, Trifluoperazine, and Sulpiride. Atypical include; Amisulpride, Aripiprazole, Clozapine, Olanzapine, Quetiapine and Risperidone. Atypical antipsychotics, are useful in patients that do not respond to treatment with typical antipsychotics. They cause less extrapyramidal side effects and have a greater efficacy to treat negative symptoms. Atypical antipsychotics also block dopamine, but to a lesser degree than the older drugs. They also work on serotonin. Some antipsychotics are available in depot form, i.e. Haloperidol decanoate, Flupenthixol decanoate, Fluphenazine decanoate, Pipothiazine palmitate and Zuclopenthixol decanoate. These are injected into muscle every 2 to 4 weeks and release slowly over time. This prevents patients forgetting to take their medication. sales@chiron.no Tel.: Fax.: BMF 84 p.1/6, 11_16

2 Chiron offer a range of antipsychotic reference materials and associated internal standards; Catalogue No. Description Cas No. Concentration Solvent Volume Aripiprazole (Abilify) AN Aripiprazole µg/ml acetonitrile 1 ml K-AN Aripiprazole µg/ml acetonitrile 1 ml MG Aripiprazole neat neat 10 mg MG Aripiprazole neat neat 25 mg AN Aripiprazole-d8 (butyl-d8) µg/ml acetonitrile 1 ml K-ME Amisulpride (Solian) Dehydroaripiprazole hydrochloride (Aripiprazole Impurity E) µg base/ml methanol 1 ml MG (+/-)-Amisulpride neat neat 10 mg MG (+/-)-Amisulpride neat neat 50 mg MG (+/-)-Amisulpride neat neat 100 mg Chlorpromazine (Largactil) K-ME Chlorpromazine hydrochloride µg base/ml methanol 1 ml MG Chlorpromazine hydrochloride neat neat 50 mg MG Chlorpromazine hydrochloride neat neat 100 mg ME Clozapine (Clozaril) Chlorpromazine-d6 oxalate (N,N-dimethyl-d6) µg/ml methanol 1 ml ME Clozapine µg/ml methanol 1 ml K-ME Clozapine µg/ml methanol 1 ml MG Clozapine neat neat 10 mg MG Clozapine neat neat 25 mg MG Clozapine neat neat 100 mg ME K-ME MG K-ME Clozapine-d4 (4-methylpiperazinyl-2,2,6,6-d4) Clozapine-d4 (4-methylpiperazinyl-2,2,6,6-d4) Clozapine-d4 (4-methylpiperazinyl-2,2,6,6-d4) Norclozapine (N-Desmethylclozapine) µg/ml methanol 1 ml µg/ml methanol 1 ml neat neat 10 mg µg/ml methanol 1 ml ME Clozapine N-oxide µg/ml methanol 1 ml K-ME Clozapine N-oxide µg/ml methanol 1 ml Droperidol MG Droperidol neat neat 10 mg Flupentixol K-ME MG Flupentixol dihydrochloride (cis+trans) Flupentixol dihydrochloride (cis+trans) µg base/ml methanol 1 ml neat neat 10 mg sales@chiron.no Tel.: Fax.: BMF 84 p.2/6, 11_16

3 Catalogue No. Description Cas No. Concentration Solvent Volume K-ME MG Fluphenazine cis-(z)-flupentixol dihydrochloride cis-(z)-flupentixol dihydrochloride µg base/ml methanol 1 ml neat neat 10 mg K-ME Fluphenazine dihydrochloride µg base/ml methanol 1 ml MG Fluphenazine dihydrochloride neat neat 10 mg Fluspirilene MG Fluspirilene neat neat 10 mg Haloperidol (Haldol) K-ME Haloperidol µg/ml methanol 1 ml MG Haloperidol neat neat 50 mg ME Haloperidol-d4 (4-chlorophenyl-d4) µg/ml methanol 1 ml Olanzapine (Zyprexa) K-ME Levomepromazine maleate µg base/ml methanol 1 ml MG Levomepromazine maleate neat neat 10 mg MG Levomepromazine maleate neat neat 50 mg Olanzapine (Zyprexa) AN Olanzapine µg/ml acetonitrile 1 ml K-AN Olanzapine µg/ml acetonitrile 1 ml MG Olanzapine neat neat 10 mg MG Olanzapine neat neat 25 mg MG Olanzapine neat neat 100 mg MG Olanzapine neat neat 250 mg G Olanzapine neat neat 1 g AN Olanzapine-d3 (N-methyl-d3) µg/ml acetonitrile 1 ml ME Olanzapine 10-N-β-D-glucuronide µg/ml methanol 1 ml K-AN Perphenazine N-Demethylolanzapine (4 -Desmethylolanzapine, Olanzapine Impurity A) µg/ml acetonitrile 1 ml MG Perphenazine neat neat 10 mg MG Prochloroperazine Perphenazine-d4 (phenothiazine-1,3,7,9-d4) neat neat 10 mg MG Prochloroperazine maleate neat neat 10 mg Promazine K-ME Promazine hydrochloride µg base/ml methanol 1 ml MG Promazine hydrochloride neat neat 10 mg sales@chiron.no Tel.: Fax.: BMF 84 p.3/6, 11_16

4 Catalogue No. Description Cas No. Concentration Solvent Volume K-ME MG Quetiapine 2-(1-Hydroxypropyl)promazine (10H-Phenothiazine-2-methanol) 2-(1-Hydroxypropyl)promazine (10H-Phenothiazine-2-methanol) µg/ml methanol 1 ml neat neat 10 mg K-ME Quetiapine hemifumarate µg base/ml methanol 1 ml MG Quetiapine hemifumarate neat neat 10 mg Risperidone K-ME Risperidone µg/ml methanol 1 ml MG Risperidone neat neat 10 mg MG Risperidone neat neat 25 mg K-ME MG MG Thioridazine (+/-)-9-Hydroxyrisperidone (Paliperidone, Risperidone Impurity C) 9-Hydroxyrisperidone (Paliperidone, Risperidone Impurity C) 9-Hydroxyrisperidone (Paliperidone, Risperidone Impurity C) µg/ml methanol 1 ml neat neat 10 mg neat neat 25 mg K-ME Thioridazine hydrochloride µg base/ml methanol 1 ml Trifluoperazine K-ME Trifluoperazine dihydrochloride µg base/ml methanol 1 ml MG Trifluoperazine dihydrochloride neat neat 10 mg Triflupromazine K-ME MG Trimipramine Triflupromazine hydrochloride (Trifluopromazine HCl) Triflupromazine hydrochloride (Trifluopromazine HCl) µg base/ml methanol 1 ml neat neat 10 mg K-ME Trimipramine maleate µg/ml methanol 1 ml MG Trimipramine maleate neat neat 10 mg ME MG Zuclopenthixol Trimipramine-d3 maleate (N-methyl-d3) Trimipramine-d3 maleate (N-methyl-d3) µg/ml methanol 1 ml neat neat 10 mg MG Zuclopenthixol (cis+trans) neat neat 10 mg MG Zuclopenthixol acetate (cis+trans) neat neat 10 mg MG cis-(z)-zuclopenthixol succinate (free base) neat neat 1 mg MG cis-(z)-zuclopenthixol-d4 succinate (N-hydroxyethyl-d4) (as trans-isomer) neat neat 1 mg sales@chiron.no Tel.: Fax.: BMF 84 p.4/6, 11_16

5 Catalogue No. Description Cas No. Concentration Component part Antipsychotic & Antidepressant Mix 7 Compounds at 25 μmol/l (0.025 μmol/ml) (freebase) Haloperidol [ ] 25 µmol/l Olanzapine [ ] 25µmol/L N-Desmethylolanzapine [ ] 25 µmol/l Risperidone [ ] 25 µmol/l Hydroxyrisperidone [ ] 25 µmol/l Mirtazapine [ ] 25 µmol/l Desmethylmirtazapine hydrochloride [ ] 25 µmol/l S uM-ME S uM-MEx5 1 x 1 ml ampoule 5 x 1 ml ampoules! Chiron AS is an authorised distributor of ACQ Science. Please contact us for information on ACQ Science antipsychotic (Neuroleptic) accuracy controls in serum. sales@chiron.no Tel.: Fax.: BMF 84 p.5/6, 11_16

6 For ordering and information about prices and delivery in your country, please contact your local distributor: Tel.: Fax.: BMF 84 p.6/6, 11_16

Formulary Item Restrictions and/or Advice Site availability

Formulary Item Restrictions and/or Advice Site availability Formulary Item Restrictions and/or Advice Site availability C&W CNWL Typical Antipsychotic drugs Chlorpromazine 25mg Chlorpromazine 50mg Chlorpromazine 100mg Chlorpromazine 25mg/5ml syrup Chlorpromazine

More information

Antidepressants. BMF 83 - Antidepressants

Antidepressants. BMF 83 - Antidepressants Antidepressants BMF 83 - Antidepressants Depression is a common psychiatric disorder impacting millions of people worldwide. It is caused by an imbalance of chemicals in the brain, namely serotonin and

More information

Antipsychotics. This factsheet covers -

Antipsychotics. This factsheet covers - Antipsychotics If you experience psychosis as part of an illness, you may be offered antipsychotic medication. Antipsychotics are generally used to treat psychosis, but are also used to treat bipolar disorder

More information

This factsheet covers:

This factsheet covers: Antipsychotics If you experience psychosis as part of your illness, you may be offered antipsychotic medication. Antipsychotics are generally used to treat psychosis, but are also used to treat bipolar

More information

Preferred Prescribing Choices of Antipsychotic Drugs (APD) in Adults for Schizophrenia and Other Psychoses

Preferred Prescribing Choices of Antipsychotic Drugs (APD) in Adults for Schizophrenia and Other Psychoses Preferred Prescribing Choices of Antipsychotic Drugs (APD) in Adults for Schizophrenia and Other Psychoses HPFT Medicines Formulary lists the APDs that have been approved for use, however, it does not

More information

Antipsychotic Medication: Monitoring Side Effects

Antipsychotic Medication: Monitoring Side Effects Antipsychotic Medication: Monitoring Side Effects Aims Review national practice guidelines and evidence regarding current standards of care. Discuss clinical implications of AP side effects. Reflect on

More information

1 Chapter 1 A Review on Antipsychotic Drug Substances and. Importance of Alternate Synthetic Approaches to Drug Substances

1 Chapter 1 A Review on Antipsychotic Drug Substances and. Importance of Alternate Synthetic Approaches to Drug Substances CHAPTER-1: 1 A Review on Antipsychotic Drug Substances and Importance of Alternate Synthetic Approaches to Drug Substances for Pharmaceutical Industry: PART-1: Review on Antipsychotic Drug Substances 1.1.1:

More information

South London and the Maudsley NHS Foundation Trust Medicines Formulary

South London and the Maudsley NHS Foundation Trust Medicines Formulary South London and the Maudsley NHS Foundation Trust Medicines Formulary Medicine Formulations Restrictions Additional Information / Related NICE Technology Appraisal 4.1 Hypnotics and anxiolytics 4.1.1

More information

Mental Health Medicines Management Pilot. Community Pharmacy. High Dose Antipsychotic Screening, Education & Advice Service

Mental Health Medicines Management Pilot. Community Pharmacy. High Dose Antipsychotic Screening, Education & Advice Service Mental Health Medicines Management Pilot Community Pharmacy High Dose Antipsychotic Screening, Education & Advice Service Approved Version 1 Date of First Issue Review Date Date of Issue Author / Contact

More information

Antipsychotic Medication

Antipsychotic Medication Antipsychotic Medication Mary Knutson, RN 3-7-12 Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 1 Clinical Uses of Antipsychotics Short-term: in severe depression and

More information

Antipsychotics. Neuroleptics/ Major Tranquilizers. Hiwa K. Saaed, PhD Pharmacology & Toxicology /5/18 1

Antipsychotics. Neuroleptics/ Major Tranquilizers. Hiwa K. Saaed, PhD Pharmacology & Toxicology /5/18 1 Antipsychotics Neuroleptics/ Major Tranquilizers Hiwa K. Saaed, PhD Pharmacology & Toxicology hiwa.saaed@univsul.edu.iq 2018-2019 12/5/18 1 Learning objectives Pharmacy students should: be familiar with

More information

Schizophrenia Pharmacology UNIVERSITY OF HAWAI I HILO PRE -NURSING PROGRAM

Schizophrenia Pharmacology UNIVERSITY OF HAWAI I HILO PRE -NURSING PROGRAM Schizophrenia Pharmacology UNIVERSITY OF HAWAI I HILO PRE -NURSING PROGRAM NURS 203 GENERAL PHARMACOLOGY DANITA NARCISO PHARM D Learning Objectives Understand the result of dopamine binding to D2 receptors

More information

What Team Members Other Than Prescribers Need To Know About Antipsychotics

What Team Members Other Than Prescribers Need To Know About Antipsychotics What Team Members Other Than Prescribers Need To Know About Antipsychotics The Care Transitions Network National Council for Behavioral Health Montefiore Medical Center Northwell Health New York State

More information

Pharmacy Medical Necessity Guidelines: Antipsychotic Medications

Pharmacy Medical Necessity Guidelines: Antipsychotic Medications Pharmacy Medical Necessity Guidelines: Antipsychotic Medications Effective: July. 1, 2016 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review Pharmacy

More information

Antidepressants. Dr Malek Zihlif

Antidepressants. Dr Malek Zihlif Antidepressants The optimal use of antidepressant required a clear understanding of their mechanism of action, pharmacokinetics, potential drug interaction and the deferential diagnosis of psychiatric

More information

The routine use of Intramuscular anticholinergics and depot antipsychotics BY DR. CHANTELLE MAGRI FOUNDATION YEAR 1

The routine use of Intramuscular anticholinergics and depot antipsychotics BY DR. CHANTELLE MAGRI FOUNDATION YEAR 1 The routine use of Intramuscular anticholinergics and depot antipsychotics BY DR. CHANTELLE MAGRI FOUNDATION YEAR 1 Contributors Dr. Francesca Falzon Aquilina; BST psychiatry Dr Claire Axiaq; Resident

More information

Antipsychotics Prior Authorization Criteria for Louisiana Fee for Service and MCO Medicaid Recipients

Antipsychotics Prior Authorization Criteria for Louisiana Fee for Service and MCO Medicaid Recipients Antipsychotics Prior Authorization Criteria for Louisiana Fee for Service and MCO Medicaid Recipients Preferred Agents (Oral) a Amitriptyline/Perphenazine (Generic) Aripiprazole Tablet (Generic) b Chlorpromazine

More information

National Center for Mental Health

National Center for Mental Health National Center for Mental Health 9 de Febrero St., Mandaluyong City Telephone No.: 531-91 Organizational Structure Medical Center Chief II Chief, Medical and Professional Staff (Hospital Service) Chief,

More information

Pharmacy Benefit Management (PBM) Program FORMULARY/PRODUCT RESTRICTIONS

Pharmacy Benefit Management (PBM) Program FORMULARY/PRODUCT RESTRICTIONS Workforce Safety & Insurance Revised Document Date: 07/21/2015 1600 E Century Ave Ste 1 PO Box 5585 Bismarck, ND 58506-5585 701.328.3800 1.800.777.5033 www.workforcesafety.com Pharmacy Benefit Management

More information

Special Project. National Mental Health Benchmarking Project Forensic Forum. Seclusion Medication Audit

Special Project. National Mental Health Benchmarking Project Forensic Forum. Seclusion Medication Audit National Mental Health Benchmarking Project Forensic Forum Special Project Seclusion Medication Audit A joint Australian, State and Territory Government Initiative October 2007 National Benchmarking Project

More information

Chapter 17. Psychoses. Classifications of Psychoses. Schizophrenia. Factors Attributed to Development of Psychoses

Chapter 17. Psychoses. Classifications of Psychoses. Schizophrenia. Factors Attributed to Development of Psychoses Chapter 17 Psychoses Drugs for Psychoses Delusions Hallucinations Illusions Paranoia Upper Saddle River, New Jersey 07458 All rights reserved. Classifications of Psychoses Acute episode Chronic episode

More information

Treat Schizophrenia Schizoaffective disorder Bipolar disorder Psychotic depression Off-label uses Insomnia Tics Delirium Stuttering

Treat Schizophrenia Schizoaffective disorder Bipolar disorder Psychotic depression Off-label uses Insomnia Tics Delirium Stuttering Robert M. Millay RN MSN Ed Professor, Napa Valley College Psychiatric Technician Programs Copyright 2015, 2011, 2007, 2003, 1999, 1995, 1991 by Mosby, an imprint of Elsevier Inc. Treat Schizophrenia Schizoaffective

More information

SHARED CARE GUIDELINE

SHARED CARE GUIDELINE SHARED CARE GUIDELINE Title: Prescribing and/ or Monitoring of Antipsychotics Scope: Pennine Care NHS Foundation Trust NHS Bury NHS Oldham NHS Heywood, Middleton and Rochdale NHS Stockport NHS Tameside

More information

National Center for Mental Health

National Center for Mental Health National Center for Mental Health 9 de Febrero St., Mandaluyong City Telephone No.: 531-9001 (c/o Dr. Vinluan) Organizational Structure Medical Center Chief II Chief, Medical and Professional Staff (Hospital

More information

Objectives. Epidemiology. Diagnosis 3/27/2013. Identify positive and negative symptoms used for diagnosis of schizophrenia

Objectives. Epidemiology. Diagnosis 3/27/2013. Identify positive and negative symptoms used for diagnosis of schizophrenia Objectives Identify positive and negative symptoms used for diagnosis of schizophrenia Mohamed Sallout, Pharm D. Pharmacist Resident St. Luke s Magic Valley Regional Medical Center List medications used

More information

ANTIPSYCHOTICS/ NEUROLEPTICS

ANTIPSYCHOTICS/ NEUROLEPTICS Pharmacological Interventions Tutorial Antipsychotic medications First Generation (Typicals) Includes phenothiazines, thioxanthenes, butyrophenones ANTIPSYCHOTICS/ NEUROLEPTICS Second Generation (Atypicals)

More information

Measure #383 (NQF 1879): Adherence to Antipsychotic Medications For Individuals with Schizophrenia National Quality Strategy Domain: Patient Safety

Measure #383 (NQF 1879): Adherence to Antipsychotic Medications For Individuals with Schizophrenia National Quality Strategy Domain: Patient Safety Measure #383 (NQF 1879): Adherence to Antipsychotic Medications For Individuals with Schizophrenia National Quality Strategy Domain: Patient Safety 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

More information

SP.236 / ESG.SP236 Exploring Pharmacology Spring 2009

SP.236 / ESG.SP236 Exploring Pharmacology Spring 2009 MIT OpenCourseWare http://ocw.mit.edu SP.236 / ESG.SP236 Exploring Pharmacology Spring 2009 For information about citing these materials or our Terms of Use, visit: http://ocw.mit.edu/terms. Atypical (2

More information

CHLORPROMAZINE EQUIVALENTS VERSUS DEFINED DAILY DOSES: HOW TO COMPARE ANTIPSYCHOTIC DRUG DOSES?

CHLORPROMAZINE EQUIVALENTS VERSUS DEFINED DAILY DOSES: HOW TO COMPARE ANTIPSYCHOTIC DRUG DOSES? CHLORPROMAZINE EQUIVALENTS VERSUS DEFINED DAILY DOSES: HOW TO COMPARE ANTIPSYCHOTIC DRUG DOSES? C.A.W. Rijcken 1, T.B.M. Monster 1, J.R.B.J. Brouwers 1, L.T.W. de Jong van den Berg 1 1 Department of Social

More information

Document Title Antipsychotics Prescribing Guidelines for Schizophrenia

Document Title Antipsychotics Prescribing Guidelines for Schizophrenia Document Title Antipsychotics Prescribing Guidelines for Schizophrenia Document Description Document Type Prescribing Guidance Service Application Medicines Management Version 1.0 Policy Reference no.

More information

Providing an overview of antipsychotic drugs: is schizophrenia a psychiatric challenge?

Providing an overview of antipsychotic drugs: is schizophrenia a psychiatric challenge? Providing an overview of antipsychotic drugs: is schizophrenia a psychiatric challenge? Abstract Natalie Schellack, BCur, BPharm, PhD(Pharmacy), Senior Lecturer Moliehi Matlala, BPharm, MSc(Med) Pharmacy,

More information

Chapter 161 Antipsychotics

Chapter 161 Antipsychotics Chapter 161 Antipsychotics Episode Overview Extrapyramidal syndromes are a common complication of antipsychotic medications. First line treatment is benztropine or diphenhydramine. Lorazepam is used in

More information

Method. NeuRA First versus second generation antipsychotics August 2016

Method. NeuRA First versus second generation antipsychotics August 2016 Introduction First generation typical are an older class of antipsychotic than second generation atypical. First generation are used primarily to treat positive symptoms including the experiences of perceptual

More information

Joint Formulary for Psychotropic Medication.

Joint Formulary for Psychotropic Medication. Joint for Psychotropic Medication. This document has been produced in collaboration with the Lancashire Commissioning Support Unit Page 1 Table of Contents Section Page Number Page 2 Definition of categories

More information

This document has been produced in collaboration with the Lancashire Commissioning Support Unit

This document has been produced in collaboration with the Lancashire Commissioning Support Unit Joint for Psychotropic Medication. This document has been produced in collaboration with the Lancashire Commissioning Support Unit Date: December 2014. Reviewed August 2016. Next review Date April 2019

More information

Modern Treatments. Modern Treatments for Schizophrenia

Modern Treatments. Modern Treatments for Schizophrenia Modern Treatments Modern Treatments for Schizophrenia The brain is the most complex organ of the human body and it therefore follows that it s disorders are equally complex. Mental disorders such as schizophrenia

More information

Antipsychotic Prescribing Audit:

Antipsychotic Prescribing Audit: Antipsychotic Prescribing Audit: Measuring the impact of a prescribing intervention Audit Co-ordinator/ Author of Report: Supervisor: Professor Shôn W Lewis Table of Contents List of Tables... 3 List of

More information

Psychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis

Psychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis Psychiatric Illness In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis 12,000,000 children infants through 18 y/o nation wide 5,000,000 suffer severely Serious

More information

Providing an overview on antipsychotics: schizophrenia a psychiatric challenge? A 2017 Update

Providing an overview on antipsychotics: schizophrenia a psychiatric challenge? A 2017 Update Providing an overview on antipsychotics: schizophrenia a psychiatric challenge? A 2017 Update Schellack N, 1 BCur, BPharm, PhD (Pharmacy), Matlala M, 2 BPharm, MSc (Med) Pharmacy, PhD (Pharmacy) 1Associate

More information

AT RISK MENTAL STATES IN PSYCHOSIS AND SCHIZOPHRENIA IN CHILDREN AND YOUNG PEOPLE

AT RISK MENTAL STATES IN PSYCHOSIS AND SCHIZOPHRENIA IN CHILDREN AND YOUNG PEOPLE AT RISK MENTAL STATES IN PSYCHOSIS AND SCHIZOPHRENIA IN CHILDREN AND YOUNG PEOPLE Topic AT RISK MENTAL STATES IN PSYCHOSIS AND SCHIZOPHRENIA IN CHILDREN AND YOUNG PEOPLE Scope 4.3.1 (a) Review question(s)

More information

Objectives. Antipsychotics 7/25/2016. LeadingAge Florida 53rd Annual Convention & Exposition

Objectives. Antipsychotics 7/25/2016. LeadingAge Florida 53rd Annual Convention & Exposition Reducing the Use of Antipsychotics in Long Term Care Communities Alan W. Obringer RPh, CPh, CGP Executive Director Senior Care Pharmacy Objectives Recognize the clinical evidence for the need to change

More information

Measure #383 (NQF 1879): Adherence to Antipsychotic Medications For Individuals with Schizophrenia National Quality Strategy Domain: Patient Safety

Measure #383 (NQF 1879): Adherence to Antipsychotic Medications For Individuals with Schizophrenia National Quality Strategy Domain: Patient Safety Measure #383 (NQF 1879): Adherence to Antipsychotic Medications For Individuals with Schizophrenia National Quality Strategy Domain: Patient Safety 2017 OPTIONS F INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

HOSPITAL BASED INPATIENT PSYCHIATRIC SERVICES (HBIPS) MEASURE SET

HOSPITAL BASED INPATIENT PSYCHIATRIC SERVICES (HBIPS) MEASURE SET HOSPITAL BASED INPATIENT PSYCHIATRIC SERVICES (HBIPS) MEASURE SET Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: February, 2013 Most recently revised: December 2018 The Psychiatric Measure Set CMS

More information

Antipsychotic Medications Age and Step Therapy

Antipsychotic Medications Age and Step Therapy Market DC *- Florida Healthy Kids Antipsychotic Medications Age and Step Therapy Override(s) Approval Duration Prior Authorization 1 year Quantity Limit *Virginia Medicaid See State Specific Mandates *Indiana

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Huybrechts KF, Hernández-Díaz S, Patorno E, et al. Antipsychotic use in pregnancy and the risk for congenital malformations. JAMA Psychiatry. Published online August 17, 2016.

More information

University of Groningen. Pharmacy data as a tool for assessing antipsychotic drug use Rijcken, Claudia

University of Groningen. Pharmacy data as a tool for assessing antipsychotic drug use Rijcken, Claudia University of Groningen Pharmacy data as a tool for assessing antipsychotic drug use Rijcken, Claudia IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Invega Sustenna, Invega Trinza) Reference Number: CP.PHAR.291 Effective Date: 12.01.16 Last Review Date: 08.18 Line of Business: Medicaid See Important Reminder at the end of this policy

More information

Sponsored by the Neuroscience Education Institute Additionally sponsored by the American Society for the Advancement of Pharmacotherapy

Sponsored by the Neuroscience Education Institute Additionally sponsored by the American Society for the Advancement of Pharmacotherapy The Future of Antipsychotic Therapy (page 7 in syllabus) Stephen M. Stahl, MD, PhD Adjunct Professor, Department of Psychiatry University of California, San Diego School of Medicine Honorary Visiting Senior

More information

Antipsychotics by Cayte Hoppner (updated by Glenice Bateman, Pharmacist, 2011)

Antipsychotics by Cayte Hoppner (updated by Glenice Bateman, Pharmacist, 2011) Antipsychotics by Cayte Hoppner (updated by Glenice Bateman, Pharmacist, 2011) Introduction Antipsychotics are the foundation of pharmacological treatment of schizophrenia and other psychotic illnesses.

More information

The antipsychotic drugs (also called neuroleptics or major tranquilizers) are used primarily to treat schizophrenia, but they are also effective in

The antipsychotic drugs (also called neuroleptics or major tranquilizers) are used primarily to treat schizophrenia, but they are also effective in Antipsychotic Drugs The antipsychotic drugs (also called neuroleptics or major tranquilizers) are used primarily to treat schizophrenia, but they are also effective in other psychotic and manic states.

More information

MO Medicaid Foster Care Drugs FY10-FY14

MO Medicaid Foster Care Drugs FY10-FY14 MO Medicaid Foster Care Drugs FY10-FY14 Medicaid (MO HealthNet) Cost of Drugs given to Missouri Foster Care Children by combinations of Age, Gender, Drug Class and Fiscal Year [Raw Data Provided by Missouri

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 30 November 2011

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 30 November 2011 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 30 November 2011 List of medicines concerned: SECOND-GENERATION ORAL ANTIPSYCHOTICS SOLIAN 100 mg, 200 mg, 400 mg

More information

Medications and Children Disorders

Medications and Children Disorders Mental Health Comprehensive Services Providing Family Stability and Developing Life Coping Skills Medications and Children Disorders Psychiatric medications can be an effective part of the treatment for

More information

TRANSPARENCY COMMITTEE

TRANSPARENCY COMMITTEE The legally binding text is the original French version TRANSPARENCY COMMITTEE Opinion 19 November 2014 LATUDA 18.5 mg, film-coated tablet B/28 (CIP: 3400927887130) LATUDA 37 mg, film-coated tablet B/28

More information

Schizophrenia and Antipsychotic Medications

Schizophrenia and Antipsychotic Medications Schizophrenia and Antipsychotic Medications Model Curriculum Michael D. Jibson, M.D., Ph.D. Ira D. Glick, M.D. American Society for Clinical Psychopharmacology Pretest 1. Negative symptoms of schizophrenia

More information

First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness

First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness 1 First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness This continuing education monograph examines the results of a comparative effectiveness review to compare

More information

A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer

A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer A Brief Overview of Psychiatric Pharmacotherapy Joel V. Oberstar, M.D. Chief Executive Officer Disclosures Some medications discussed are not approved by the FDA for use in the population discussed/described.

More information

Antipsychotics. Something Old, Something New, Something Used to Treat the Blues

Antipsychotics. Something Old, Something New, Something Used to Treat the Blues Antipsychotics Something Old, Something New, Something Used to Treat the Blues Objectives To provide an overview of the key differences between first and second generation agents To an overview the newer

More information

Use of Antipsychotics in General Practice

Use of Antipsychotics in General Practice Date : November, 01, 2009 Publication : Medical Chronicle Page Number: 75-76 Use of Antipsychotics in General Practice Page 1 / 5 Size=33SCKS$&imn OftraUftbonl 1999KSeddEserpp119999 Date : November, 01,

More information

Michael J. Bailey, M.D. OptumHealth Public Sector

Michael J. Bailey, M.D. OptumHealth Public Sector Michael J. Bailey, M.D. OptumHealth Public Sector LIHP Quality Charter To ensure the quality of care delivered to enrollees in San Diego County Assistance Programs, such as County Medical Services (CMS)

More information

Chapter 4 ~ Central nervous system

Chapter 4 ~ Central nervous system Chapter 4 ~ Central Nervous System: Special Section 1 of 5 Chapter 4 ~ Central nervous system 4.1 Hypnotics and anxiolytics 4.1.1 Hypnotics LOPRAZOLAM Tablet 1mg LORMETAZEPAM Tablet 500microgram PROMETHAZINE

More information

High Dose Antipsychotic Therapy (HDAT) guideline

High Dose Antipsychotic Therapy (HDAT) guideline Document level: Trustwide (TW) Code: MP18 Issue number: 2 High Dose Antipsychotic Therapy (HDAT) guideline Lead executive Medical Director Author and contact number Lead Clinical Pharmacist 01625 663 857

More information

Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017

Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017 Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist HMS Training Webinar January 27, 2017 1 Describe nationwide prevalence and types of elderly dementia + define BPSD Define psychotropic

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Abilify Maintena, Aristada, Aristada Initio) Reference Number: CP.PHAR.290 Effective Date: 12.01.16 Last Review Date: 08.18 Line of Business: Medicaid Coding Implications Revision Log

More information

Slide 1. Slide 2. Slide 3. About this module. About this module. Antipsychotics: The Essentials Module 5 A Primer on Selected Antipsychotics

Slide 1. Slide 2. Slide 3. About this module. About this module. Antipsychotics: The Essentials Module 5 A Primer on Selected Antipsychotics Slide 1 Antipsychotics: The Essentials Module 5 A Primer on Selected Antipsychotics Flavio Guzmán, MD Slide 2 About this module 13 antipsychotics will be studied 3 first generation antipsychotics 10 second

More information

Clinical Policy: Olanzapine Long-Acting Injection (Zyprexa Relprevv) Reference Number: CP.PHAR.292 Effective Date: Last Review Date: 08.

Clinical Policy: Olanzapine Long-Acting Injection (Zyprexa Relprevv) Reference Number: CP.PHAR.292 Effective Date: Last Review Date: 08. Clinical Policy: (Zyprexa Relprevv) Reference Number: CP.PHAR.292 Effective Date: 12.01.16 Last Review Date: 08.18 Line of Business: Medicaid See Important Reminder at the end of this policy for important

More information

Safe transfer of prescribing guidance

Safe transfer of prescribing guidance Safe transfer of prescribing guidance TEWV Prescriber Summary Application required before prescribing Products requiring an application, before prescribing, using the single application form Unlicensed

More information

Woman Looking Through Opera Glasses, oil on cardboard c , Edgar Degas, Galerie Neue Meister, Dresden.

Woman Looking Through Opera Glasses, oil on cardboard c , Edgar Degas, Galerie Neue Meister, Dresden. RISPERIDONE Woman Looking Through Opera Glasses, oil on cardboard c. 1869-77, Edgar Degas, Galerie Neue Meister, Dresden. I do not like carriages. One sees no one. That is why I love the omnibus. One can

More information

Extrapyramidal Symptoms Associated with Antipsychotic Use

Extrapyramidal Symptoms Associated with Antipsychotic Use Extrapyramidal Symptoms Associated with Antipsychotic Use Tamara Pringsheim, MD, FRCPC, FAAN Associate Professor, University of Calgary Department of Clinical Neurosciences, Psychiatry, Pediatrics and

More information

Proposed Changes to Existing Measure for HEDIS : Adherence to Antipsychotic Medications for Individuals With Schizophrenia (SAA)

Proposed Changes to Existing Measure for HEDIS : Adherence to Antipsychotic Medications for Individuals With Schizophrenia (SAA) Proposed Changes to Existing Measure for HEDIS 1 2020: Adherence to Antipsychotic Medications for Individuals With Schizophrenia (SAA) NCQA seeks comments on proposed modifications to the HEDIS Health

More information

Charles P. Samenow, MD, MPH Department of Psychiatry George Washington University

Charles P. Samenow, MD, MPH Department of Psychiatry George Washington University Charles P. Samenow, MD, MPH Department of Psychiatry George Washington University Objectives Identify the epidemiology, symptomatology, course, causality (including genetic risk) and treatment options

More information

Kelly E. Williams, Pharm.D. PGY2 Psychiatric Pharmacy Resident April 16,2009

Kelly E. Williams, Pharm.D. PGY2 Psychiatric Pharmacy Resident April 16,2009 Kelly E. Williams, Pharm.D. PGY2 Psychiatric Pharmacy Resident April 16,2009 List the antipsychotics most often prescribed Compare and contrast the use and adverse effects experienced in the pediatric

More information

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder

More information

Antipsychotic Use in the Elderly

Antipsychotic Use in the Elderly Antipsychotic Use in the Elderly Presented by: Fatima M. Ali, PharmD, RPh, BCPS Clinical Consultant Pharmacist MediSystem Pharmacy, Kingston Originally Prepared by: Nicole Tisi BScPhm, RPh ACPR Disclosure

More information

Table of Contents. 1.0 Policy Statement...1

Table of Contents. 1.0 Policy Statement...1 Division of Medical Assistance General Clinical Policy No. A-6 Table of Contents 1.0 Policy Statement...1 2.0 Policy Guidelines...1 2.1 Eligible Recipients...1 2.1.1 General Provisions...1 2.1.2 EPSDT

More information

CLOZAPINE. Clozapine, (trade name Clopine and Clozaril in Australia) is a second generation atypical antipsychotic agent.

CLOZAPINE. Clozapine, (trade name Clopine and Clozaril in Australia) is a second generation atypical antipsychotic agent. CLOZAPINE Introduction Clozapine, (trade name Clopine and Clozaril in Australia) is a second generation atypical antipsychotic agent. Due to its potential for significant toxicity, it is reserved for patients

More information

NEUROPSYCHIATRY DSM (PYDI 0416) FALL, 1999 MEDICINAL CHEMISTRY OF ANTIPSYCHOTICS DR. RILEY A. INTRODUCTION

NEUROPSYCHIATRY DSM (PYDI 0416) FALL, 1999 MEDICINAL CHEMISTRY OF ANTIPSYCHOTICS DR. RILEY A. INTRODUCTION EUPYCIATY DM (PYDI 0416) ALL, 1999 MEDICIAL CEMITY ATIPYCTIC D. ILEY A. ITDUCTI Antipsychotic (neuroleptic) agents are primarily used in the therapy of schizophrenia, organic psychoses, the manic phase

More information

Thorazine 25 Mg Iv chlorpromazine hcl 50 mg chlorpromazine 10 mg chlorpromazine tablets uses chlorpromazine tablets ip 100mg thorazine ivpb

Thorazine 25 Mg Iv chlorpromazine hcl 50 mg chlorpromazine 10 mg chlorpromazine tablets uses chlorpromazine tablets ip 100mg thorazine ivpb Thorazine 25 Mg Iv 1 thorazine cost 2 chlorpromazine thorazine for hiccups 3 chlorpromazine injection dosage 4 recreational thorazine uses 5 chlorpromazine 25 mg/2ml 6 chlorpromazine hcl 50 mg 7 buy chlorpromazine

More information

MMG012 GUIDELINES FOR THE USE OF HIGH DOSE ANTIPSYCHOTIC MEDICATION

MMG012 GUIDELINES FOR THE USE OF HIGH DOSE ANTIPSYCHOTIC MEDICATION MMG012 GUIDELINES FOR THE USE OF HIGH DOSE ANTIPSYCHOTIC MEDICATION Page 1 of 16 Table of Contents Why we need this Policy... 3 What the Policy is trying to do... 3 Which stakeholders have been involved

More information

Treatment of Schizophrenia Appendix Three Page 1 of 8

Treatment of Schizophrenia Appendix Three Page 1 of 8 Prescribing Guidelines Treatment of Schizophrenia Scope of this guidance This guidance aims to describe the pharmacological management of schizophrenia at a simple and intermediate level, with a brief

More information

Professor David Castle. Ms. Nga Tran. St. Vincent s Mental Health Level 2, 46 Nicholson Street, Fitzroy Vic 3065

Professor David Castle. Ms. Nga Tran. St. Vincent s Mental Health Level 2, 46 Nicholson Street, Fitzroy Vic 3065 ARABIIC Professor David Castle Ms. Nga Tran St. Vincent s Mental Health Level 2, 46 Nicholson Street, Fitzroy Vic 3065 (03) 9288 4147 (03) 9288 4751 Psychiatric Medication Information / Arabic 1 Psychiatric

More information

Guidelines on Choice and Selection of Antipsychotics for the Management of Psychosis and Schizophrenia in Adults

Guidelines on Choice and Selection of Antipsychotics for the Management of Psychosis and Schizophrenia in Adults Working in partnership: Hertfordshire Partnership University NHS Foundation Trust East and North Hertfordshire Clinical Commissioning Group Herts Valleys Clinical Commissioning Group Guidelines on Choice

More information

Atypical Antipsychotic Use for the Behavioural and Psychological Symptoms of Dementia in the Elderly

Atypical Antipsychotic Use for the Behavioural and Psychological Symptoms of Dementia in the Elderly Overall Comprehensive Research Plan: Atypical Antipsychotic Use for the Behavioural and Psychological Symptoms of Dementia in the Elderly October 9, 2014 30 Bond Street, Toronto ON, M5B 1W8 www.odprn.ca

More information

GUIDELINES FOR THE USE OF ARIPIPRAZOLE LONG-ACTING INJECTION (ABILIFY MAINTENA)

GUIDELINES FOR THE USE OF ARIPIPRAZOLE LONG-ACTING INJECTION (ABILIFY MAINTENA) GUIDELINES FOR THE USE OF ARIPIPRAZOLE LONG-ACTING INJECTION (ABILIFY MAINTENA) Introduction Aripiprazole long-acting injection (LAI)is licensed for the maintenance treatment of adult patients with schizophrenia

More information

High Dose Antipsychotic Therapy (HDAT) guideline

High Dose Antipsychotic Therapy (HDAT) guideline Document level: Trustwide (TW) Code: MP18 Issue number: 4 High Dose Antipsychotic Therapy (HDAT) guideline Lead executive Medical Director Authors details Michael Slater (Clinical Pharmacist, tel. 01625

More information

Psychotropic Medication Use in Dementia

Psychotropic Medication Use in Dementia Psychotropic Medication Use in Dementia Marie A DeWitt, MD Diplomate of the American Board of Psychiatry and Neurology, Specialization in Psychiatry & Subspecialization in Geriatric Psychiatry Staff Physician,

More information

TERAPI FARMAKOLOGI ANTIPSIKOTIK

TERAPI FARMAKOLOGI ANTIPSIKOTIK TERAPI FARMAKOLOGI ANTIPSIKOTIK dr. sufi desrini M.Sc Blok Kesehatan Jiwa 14/11/2014 [10] 1 Tujuan Belajar Mengetahui golongan obat antipsikotik Menjelaskan mekanisme kerja obat Menjelaskan FK dan FD masing-masing

More information

CHAPTER 3. Schizophrenia and Antipsychotic Treatment

CHAPTER 3. Schizophrenia and Antipsychotic Treatment CHAPTER 3 Schizophrenia and Antipsychotic Treatment What is it? It is a severe, chronic, disabling brain disease Considered to have biological origins but exact unknown 1% of population affected Schizophrenia

More information

Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria

Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria Drug/Drug Class Antipsychotics Clinical Criteria Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria Prior

More information

Drug Utilization Pattern of Antipsychotics in Norway:

Drug Utilization Pattern of Antipsychotics in Norway: Faculty of health sciences / Department of community medicine Drug Utilization Pattern of Antipsychotics in Norway: A Registry based study from 2004-2014 Siddhartha Luitel HEL-3950 Master s thesis in Public

More information

Prescription of High Dose Antipsychotic Medication

Prescription of High Dose Antipsychotic Medication Subject (M1) Title Medicine Prescription of High Dose Antipsychotic Medication Manual Mental Health Procedure No M1-P-2-MH Department Pharmacy Distribution All Author Rae McKnight Review 4 Reviewer Jonathan

More information

ANTIPSYCHOTICS: Clinical Pharmacology

ANTIPSYCHOTICS: Clinical Pharmacology ANTIPSYCHOTICS: Clinical Pharmacology Celso Arango carango@hggm.es www.hggm.es/ua www.cibersam.es Pre-Lecture Test Question 1 1. Which of the following is an antipsychotic dose that is in excess of the

More information

Use of Psychotropic Medications in Older Adults with Dementia!

Use of Psychotropic Medications in Older Adults with Dementia! Use of Psychotropic Medications in Older Adults with Dementia! Deepa Pattani, PharmD, RPh Owner: PrevInteract Health Deepa.Pattani@PrevInteract.com 972-372-9775 About Me Deepa Pattani, PharmD, RPh with

More information

Medicines Formulary BNF Section 4 Central Nervous System

Medicines Formulary BNF Section 4 Central Nervous System Medicines BNF Section 4 4.1 Hypnotics and anxiolytics Chloral Hydrate 500mg/5ml Solution Clomethiazole 192mg Capsules Lormetazepam Tablets Melatonin Capsules Nitrazepam Suspension Nitrazepam Tablets Temazepam

More information

HEDIS BEHAVIORAL HEALTH RESOURCE GUIDE

HEDIS BEHAVIORAL HEALTH RESOURCE GUIDE HEDIS BEHAVIORAL HEALTH RESOURCE GUIDE What is HEDIS? 3 HEDIS Reference Guide for Behavioral Health 4 Behavioral Health HEDIS Measures 13 WHAT IS HEDIS? HEDIS (Healthcare Effectiveness Data and Information

More information

Biological Psych Schizophrenia

Biological Psych Schizophrenia Biological Psych Schizophrenia Psychotic disorders The Schizophrenias 1% incidence More likely in US & Europe 10 to 100 times Slightly more common in men Earlier onset, more severe Originally: dementia

More information

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children Judges Reference Table for the Psychotropic Medication Utilization Parameters for Foster Children Stimulants for treatment of ADHD Preschool (Ages 3-5 years) Child (Ages 6-12 years) Adolescent (Ages 13-17

More information

Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response

Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response (2004) 9, 442 473 & 2004 Nature Publishing Group All rights reserved 1359-4184/04 $25.00 www.nature.com/mp FEATURE REVIEW Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic

More information